Long-term clinical outcomes after coronary artery bypass graft versus everolimus-eluting stent implantation in chronic hemodialysis patients
Authors:
- 1 September 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 29 (6) , 489-494
Abstract
It remains controversial whether coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) should be optimized to treat coronary artery disease in patients on chronic hemodialysis (HD). Recently, further refinement of drug-eluting stents, such as the everolimus-eluting stent (EES), has led to marked development in this field. We compared long-term clinical outcomes after CABG versus PCI with EES implantation in patients on chronic HD. We compared 138 patients undergoing CABG and 187 patients treated with EES implantation. The endpoint was major adverse cardiac events (MACE) as a composite outcome, including any revascularization, nonfatal myocardial infarction, or mortality. To reduce the selection bias for the two procedures, propensity score-matching was performed. During the follow-up period (43 months), 95 (29.2%) MACEs, including 43 (13.2%) revascularizations, 14 (4.3%) nonfatal myocardial infarctions, and 63 (19.4%) deaths, occurred. The freedom rate from MACE and mortality at 5 years were comparable between groups (69.7 vs. 66.7%, P=0.82 and 75.0 vs. 80.6%, P=0.10, respectively); however, those from revascularization at 5 years was higher in the CABG group than the EES group (89.4 vs. 81.0%, P=0.030). In propensity score-matched patients (n=92), the freedom rate from revascularization at 5 years was still higher in the CABG group than in the EES group (93.4 vs. 79.1%, P=0.013). Similarly, the freedom rates from MACE and mortality were comparable (70.0 vs. 66.3%, P=0.69 and 73.8 vs. 79.7%, P=0.30, respectively). Even in the second-generation drug-eluting stent era, CABG is still superior for preventing revascularization in patients on chronic HD. However, PCI with EES implantation might not have disadvantages compared with CABG in terms of MACE.Keywords
This publication has 23 references indexed in Scilit:
- Long-Term Clinical Outcome After Surgical or Percutaneous Coronary Revascularization in Hemodialysis PatientsCirculation Journal, 2014
- Long-Term Survival and Repeat Coronary Revascularization in Dialysis Patients After Surgical and Percutaneous Coronary Revascularization With Drug-Eluting and Bare Metal Stents in the United StatesCirculation, 2013
- Kidney disease in cardiologyNephrology Dialysis Transplantation, 2010
- Impact of Insulin-Treated Diabetes and Hemodialysis on Long-Term Clinical Outcomes Following Sirolimus-Eluting Stent Deployment - Insights From a Sub-Study of The Cypher Stent Japan Post-Marketing Surveillance (Cypher J-PMS) Registry -Circulation Journal, 2010
- Optimal Method of Coronary Revascularization in Patients Receiving DialysisClinical Journal of the American Society of Nephrology, 2009
- Sirolimus-Eluting Stents vs Bare Metal Stents for Coronary Intervention in Japanese Patients With Renal Failure on HemodialysisCirculation Journal, 2008
- One-Year Clinical Outcomes of Dialysis Patients After Implantation With Sirolimus-Eluting Coronary StentsCirculation Journal, 2008
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseCirculation, 2003
- Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of DiabetesCirculation, 2002
- Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal diseaseNephrology Dialysis Transplantation, 1997